The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma.

Maneix, Laure; Sweeney, Melanie A; Lee, Sukyeong; Iakova, Polina; Moree, Shannon E; Sahin, Ergun; Lulla, Premal; Yellapragada, Sarvari V; Tsai, Francis T F; Catic, Andre

Maneix, Laure; Sweeney, Melanie A; Lee, Sukyeong; Iakova, Polina; Moree, Shannon E; Sahin, Ergun; Lulla, Premal; Yellapragada, Sarvari V; Tsai, Francis T F; Catic, Andre.

Afiliação

Maneix L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Sweeney MA; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Lee S; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Iakova P; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Moree SE; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Sahin E; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Lulla P; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.
Yellapragada SV; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Tsai FTF; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Catic A; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Cancers (Basel) ; 13(4)2021 Feb 17.

Article em En | MEDLINE | ID: mdl-33671345

Palavras-chave

bortezomib; carfilzomib; drug resistance; mitoprotease; multiple myeloma; ubiquitin-proteasome system

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google